However, the simultaneous use of bevacizumab with an Ang2 inhibitor has been shown to reduce brain metastasis in the breast cancer cell lines MDA-MB-231br and 4T1br [46], so it is likely that the results of the current study can be more widely generalized to other cell lines and clinical situations. The gene discussed is ANGPT2; the disease is breast cancer.